Binder excipients act as an adhesive to hold or bind granules, powders and other dry ingredients in order to provide necessary mechanical strength to the pharmaceutical products. These excipients aid in accumulation of the powder into granules in the process called granulation, and also affect their properties such as compaction, drug release, flow, solubility, and strength. Binder excipients are used in drug formulations in order to improve disintegration, bulkiness, and bio-availability & dissolution rate of the drug. Additionally, the excipients play a key role in imparting additional value to the pharmaceutical products by improving their properties such as absorption and controlled release of the active ingredients. The Binder Excipients Market is projected to reach USD 2.3 billion by 2030 from USD 1.4 billion in 2020, at an approximate CAGR of 5.2%.

Market Segmentation:

On the basis of source, the binder excipients market can be classified into natural and synthetic. The natural source type can be further classified into animal, microbial, and plant. Based on product type, the market can be segmented into cellulosic, lactose, polyols, povidones, starch & polysaccharides, co-processed compressible excipients, and others. According to applications, the binder excipients market can be bifurcated into solution based and tablets & capsules. By end-users, the market is categorised into pharmaceutical companies, nutraceutical companies, and others. Geographically, the global binder excipients market can be broadly divided into five regions mainly North America, Europe, Asia Pacific, and RoW.

Market Dynamics and Factors:

The rising demand for several pharmaceutical products owing to ageing population and growing cases of chronic disorders are the major factors driving the binder excipients market worldwide. The recent patent expiries of a number of drugs is further expected to provide a positive boost to the demand for binder excipients in generic drug production. Some of the other notable factors aiding the market growth are advancements in nanotechnology, emergence of new excipients and rising demand for functionality excipients. The upsurge in the number of clinical trials of new drugs is likely to fuel the demand for binder excipients. However, lack of separate guidelines for manufacturing and approval of excipients is deterring R&D initiatives related to novel binder excipients. For instance, under the present regulatory scenario, if a new drug approval fails, the excipient also fails even if it is not due to anything related to the excipient. Furthermore, clinical trial data from that failed excipient is not usable. This leads to major financial loss on the part of both the drug and the excipient manufacturer and hence is a major restraining factor for the binder excipients market.

Geographic Analysis:

Asia Pacific is expected to dominate the global binder excipients market in terms of market share during the forecast period followed by North America. This is mainly because of the increase in requirement of binder excipients in the local drug manufacturing industry for generic drug business. Generic drug manufacturers in nations such as India hold a strong position in the global market and play an important role in the development of the pharmaceutical industry which in turn has created a strong demand for binder excipients for generic drugs. For instance, pharmaceutical companies in India supply over 80% of the anti-retro-viral drugs used worldwide to combat AIDS (Acquired Immuno Deficiency Syndrome). In 2017–18, India exported around 3.2 billion USD worth of generic drugs to the U.S.    

Competitive Scenario:

The key players operating in the global binder excipients market are –

DuPont de Nemours, Inc., Lonza Group, Kerry Inc., Colorcon, Croda International, EMD Millipore, Dow Chemical, FMC BioPolymer, Fuji Chemical Industry, Archer Daniels Midland and Ingredion.

Binder Excipients Market Report Scope